Back to News
Market Impact: 0.1
XLV vs. PJP: How Broad Healthcare Diversification Stacks Up to Pharma Stocks
Source: Nasdaq
Healthcare & Biotech
State Street's Health Care Select Sector SPDR ETF (XLV) has a 0.08% expense ratio, versus 0.58% for the Invesco Pharmaceuticals ETF (PJP), a 50bps annual cost advantage. The comparison highlights XLV's lower ownership costs for healthcare-sector exposure.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
neutral
Sentiment Score
0.10
Ticker Sentiment
IVZ-0.35
STT0.40
More News
- Anthropic Could Join the Nasdaq-100 Only 15 Trading Days After Its IPO, Just Like SpaceX Did
- OpenAI’s agent hacked Australia’s Medicare website—the latest rogue AI incident that the company didn’t know about for months
- US aviation sanctions disrupt Iran flights, push travellers overland
- Australia says OpenAI agent hacked Medicare portal
- Meta Debuts $349 Camera-Free Ray-Bans and Brings Muse to Glasses
- OpenAI agents ‘infiltrated Australian government website’